In a subcutaneous tumor formation assay, MARCH2-knockout (KO) TC-1 cells (Fig. S5B) showed a marked reduction in primary tumor formation compared to wild-type (WT) TC-1 cells (Fig. S5C, S5D). Here, MARCHF2 is linked to neoplasm.